FDA Import Refusal 1FX-8881898-4/30002/11 — LABORATORY BALAXI SA
The FDA refused shipment 1FX-8881898-4/30002/11 from LABORATORY BALAXI SA (Guatemala) on Jul 22, 2026. The refused product falls under Drugs and Biologics — CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC). Cited charges: 118,3280
Refusal details
- Date
- Jul 22, 2026
- Country
- Guatemala
- Product Category
- Drugs and Biologics
- Product Code
- 61FDY54 CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
- Charges
- 118,3280